Praveen Tyle

Praveen Tyle is the founder of Potens Pharmaceuticals LLC, founded in 2023.
Current jobs include Chief Executive Officer & Director at Orion Biotechnology Canada Ltd., Non-Executive Chairman at Kiora Pharmaceuticals, Inc. since 2023, Director at Interpath Pharmaceuticals, Inc., Independent Director at Orient Europharma Co. Ltd. since 2003, Director at Lipomedix Pharmaceuticals Ltd. since 2019, and Director at Maxwell Biosciences, Inc. Former jobs include President, Chief Executive Officer & Director at Osmotica Pharmaceutical Corp.
from 2013 to 2016; President, Chief Executive Officer & Director at Invectys USA, Inc.; President, Chief Executive Officer & Director at Invectys, Inc.; Non-Executive Director at Morphic Medical, Inc. in 2020; Director at Graybug Vision, Inc.; Director at Ramboda Falls Plc; Independent Director at Skye Bioscience, Inc. from 2021 to 2024; CSO, SVP-Research & Development at Bausch & Lomb, Inc. from 2004 to 2010; Chief Technical Officer & SVP-Operations at Aronex Pharmaceuticals, Inc. from 1998 to 1999; Group VP-Pharmaceutical Sciences & Manufacturing at Biovail Corp.
from 2003 to 2004; Executive Vice President-Research & Development at Lexicon Pharmaceuticals, Inc. from 2016 to 2021; Senior Advisor at Arsenal Capital Management LP; VP-Global Head & Global Pharmaceutical Sciences at Pharmacia Corp.
from 1999 to 2003; SVP, Global Head-Business Development & Licensing at Novartis Consumer Health, Inc. from 2010 to 2011; Chief Science Officer & Executive Vice President at The United States Pharmacopeia in 2012.
Education includes a doctorate from The Ohio State University conferred in 1984 and an undergraduate degree from Banaras Hindu University conferred in 1980.